Live Good Inc.

Warning LetterOpen

Jean Fuente Live Good Inc. 860 NW 27th St. Suite 051-51425 Miami , FL 33122 United States hello@sell2help.comIssued Sep 7, 2021Center for Food Safety and Applied Nutrition (CFSAN)

View Letter

Source: FDA, published letter. FDA published this warning letter; View Letter opens FDA's copy.

Letter Details

Firm: Live Good Inc.
Location: Jean Fuente Live Good Inc. 860 NW 27th St. Suite 051-51425 Miami , FL 33122 United States hello@sell2help.com
FEI Number: N/A
Country: United States
Issue Date: September 07, 2021
Issuing Office: Center for Food Safety and Applied Nutrition (CFSAN)
Product Type: Drugs
Status: Open

Summary

Live Good Inc. was cited for marketing "Berry Gen Sugar Control" as an unapproved new drug through their website, social media platforms (Facebook and Instagram), and Amazon storefront by making disease claims including that the product helps reduce blood sugar levels, control diabetes, regulate insulin, and protect the pancreas. The company violated the Federal Food, Drug, and Cosmetic Act by establishing through these marketing channels that the product was intended for the cure, mitigation, treatment, or prevention of disease without FDA approval. The FDA and Federal Trade Commission jointly reviewed the company's online sales platforms in August 2021 and determined the product claims established it as a drug requiring premarket approval before introduction into interstate commerce.